Search Browse Earnings

ASSEMBLY BIOSCIENCES, INC.

Nasdaq:ASMB

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$7.2M

FY 2024

Adj. EBITDA

-$64.2M

-896.2% margin

FY 2024

Net Income

-$61.2M

-854.8% margin

FY 2024

EPS (Diluted)

-$13.38

FY 2024

Stock Price

$29.39

+1.2%

2026-03-10

52W Range

$7.75 – $39.70

P/E Ratio

-2.2x

Market Cap

$464.8M

Cash

$19.8M

FY 2024

Total Debt

—

Net Cash

$19.8M

FY 2024

Enterprise Value

$444.9M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-6.9x

Employees

—